Cabozantinib (C) in combination with nivolumab (N) and ipilimumab (I) in previously untreated advanced renal cell carcinoma (aRCC): Final results of COSMIC-313 Meeting Abstract
| Authors: | Albiges, L.; Motzer, R. J.; Trevino, S.; Kanesvaran, R.; Centkowski, P.; Reimers, M. A.; Sade, J. P.; Pouessel, D.; Biscaldi, E.; Esteban, E.; Arija, J. A. A.; Tykodi, S. S.; Ma, H. J.; Zhou, L.; Van Kooten Losio, M. A. G.; Simmons, A.; Rangwala, F. A.; Braun, D. A.; Choueiri, T. K.; Powles, T. |
| Abstract Title: | Cabozantinib (C) in combination with nivolumab (N) and ipilimumab (I) in previously untreated advanced renal cell carcinoma (aRCC): Final results of COSMIC-313 |
| Meeting Title: | 2025 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 5 Suppl. |
| Meeting Dates: | 2025 Feb 13-15 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-02-10 |
| Language: | English |
| ACCESSION: | WOS:001454809900049 |
| DOI: | 10.1200/JCO.2025.43.5_suppl.438 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 438 -- Source: Wos |
